Literature DB >> 21883616

Human papillomavirus in adolescents: lessons learned from decades of evaluation.

Yasmin L Jayasinghe1, Elya E Moore, Sepehr N Tabrizi, Sonia R Grover, Suzanne M Garland.   

Abstract

Knowledge regarding the natural history of human papillomavirus (HPV) infection and its clinical sequelae in adolescents has increased significantly over the last decade; as a result, there have been world-wide recommendations for less aggressive Pap screening and management of cervical dysplasias in young women. It is important that adolescent health providers understand these issues, as knowledge of HPV and its sequelae in the Australian community is limited, despite the introduction of a national immunisation programme. Parents and young women have expressed a desire for further information to make informed choices. This paper reviews the natural history of HPV infection in adolescents and the evidence behind new conservative guidelines for cervical screening, plus prophylactic vaccination in young women.
© 2011 The Authors. Journal of Paediatrics and Child Health © 2011 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Mesh:

Year:  2011        PMID: 21883616     DOI: 10.1111/j.1440-1754.2011.02073.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  3 in total

Review 1.  Recommendations and barriers to vaccination in systemic lupus erythematosus.

Authors:  Megha Garg; Naaima Mufti; Tara N Palmore; Sarfaraz A Hasni
Journal:  Autoimmun Rev       Date:  2018-08-11       Impact factor: 9.754

2.  Awareness of human papillomavirus and factors associated with intention to obtain HPV vaccination among Korean youth: quasi experimental study.

Authors:  Hae Won Kim
Journal:  BMC Int Health Hum Rights       Date:  2015-02-21

Review 3.  HPV infection and vaccination in Systemic Lupus Erythematosus patients: what we really should know.

Authors:  Ingrid Herta Rotstein Grein; Noortje Groot; Marcela Ignacchiti Lacerda; Nico Wulffraat; Gecilmara Pileggi
Journal:  Pediatr Rheumatol Online J       Date:  2016-03-08       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.